COURTNEY PRICE: Open Payments
NPI 1861264327 · DILLON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 24 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $499 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $203 |
| Phathom Pharmaceuticals, Inc. | 1 | $92 |
| Novo Nordisk Inc | 2 | $52 |
| Dexcom, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: VRAYLAR, VOQUEZNA, Ozempic, Dexcom G6 Transmitter, CAPLYTA, Cologuard Collection Kit, LEQVIO, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
